Skip to main content

Market Overview

7 Biggest Mid-Day Losers For Tuesday



  • Regulus Therapeutics Inc (NASDAQ: RGLS) shares dropped 45.6 percent to $2.72 after the FDA said it had placed the company’s lead product candidate, RG-101 for the treatment of hepatitis C virus (HCV) infection, on clinical hold.
  • Celyad SA (ADR) (NASDAQ: CYAD) shares fell 36.5 percent to $26.97. Celyad reported that its CHART-1 Phase 3 trial did not meet primary endpoint.
  • COMSCORE, Inc. (NASDAQ: SCOR) shares fell 21.2 percent to $23.16. COMSCORE has delayed to file its Annual Report on Form 10-K for the year ended December 31, 2015. The company reported that its Audit Committee and Board need further time to evaluate the information collected and make final conclusions.
  • Babcock & Wilcox Enterprises Inc (NYSE: BW) declined 21 percent to $15.03 after the company lowered its 2016 earnings forecast and announced plans to cut over 200 positions in North America immediately.
  • Fibrocell Science Inc (NASDAQ: FCSC) shares dropped 12.2 percent to $1.20.
  • Medigus Ltd. (NASDAQ: MDGS) shares fell 12.1 percent to $1.14.
  • Dow Chemical Co (NYSE: DOW) shares declined 3.1 percent to $48.00. JP Morgan downgraded Dow Chemical from Overweight to Neutral.

Related Articles (RGLS + CYAD)

View Comments and Join the Discussion!

Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at